MicroRNA Expression Profiles in Superficial Esophageal Squamous Cell Carcinoma before Endoscopic Submucosal Dissection: A Pilot Study.
endoscopy
esophageal squamous cell carcinoma
microRNA
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
30 Apr 2021
30 Apr 2021
Historique:
received:
26
03
2021
revised:
26
04
2021
accepted:
28
04
2021
entrez:
5
5
2021
pubmed:
6
5
2021
medline:
28
5
2021
Statut:
epublish
Résumé
Esophageal squamous cell carcinoma (ESCC) has a poor prognosis when diagnosed at an advanced stage, and early detection and treatment are essential to improve survival. However, intraobserver and interobserver variation make the diagnosis of superficial ESCC difficult, and suitable biomarkers are urgently needed. Here, we compared the microRNA (miRNA) expression profiles of superficial ESCC tissues and adjacent normal tissues obtained immediately before esophageal endoscopic submucosal dissection. We found that ESCC and normal tissues differed in their miRNA expression profiles. In particular, miR-21-5p and miR-146b-5p were significantly upregulated and miR-210-3p was significantly downregulated in tumor tissues compared with normal tissues. We also detected significant associations between miRNA expression and ESCC invasion depth and lymphovascular invasion. The same differential expression of miR-21-5p, miR-146b-5p, and miR-210-3p was detected in ESCC cell lines compared with normal esophageal epithelial cells in vitro. However, transfection of ESCC cells with miR-210-3p and miR-21-5p mimics or inhibitors had partial effects on cell proliferation and invasion in vitro. These results indicate that miRNA expression is significantly deregulated in superficial ESCC, and suggest that the potential contribution of differentially expressed miRNAs to the malignant phenotype should be further investigated.
Identifiants
pubmed: 33946439
pii: ijms22094789
doi: 10.3390/ijms22094789
pmc: PMC8124636
pii:
doi:
Substances chimiques
MicroRNAs
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Japan Society for the Promotion of Science
ID : 20K17022
Références
JGH Open. 2019 Aug 19;4(2):178-184
pubmed: 32280762
Int J Cancer. 2011 Jan 1;128(1):132-43
pubmed: 20309880
J Pers Med. 2019 Feb 07;9(1):
pubmed: 30736475
Cell Biochem Biophys. 2013 Nov;67(2):657-68
pubmed: 23516093
Anticancer Drugs. 2019 Jan;30(1):38-45
pubmed: 30134284
J Gastroenterol Hepatol. 2018 Jun;33(6):1248-1255
pubmed: 29247549
Clin Cancer Res. 2009 Mar 15;15(6):1915-22
pubmed: 19276261
Gastroenterology. 2018 Jan;154(2):421-436
pubmed: 28778650
BMC Gastroenterol. 2017 Feb 2;17(1):24
pubmed: 28152974
J Clin Med. 2020 Dec 23;10(1):
pubmed: 33374639
J Clin Oncol. 2010 Mar 20;28(9):1566-72
pubmed: 20177025
J Pers Med. 2020 May 21;10(2):
pubmed: 32455595
Cancer Lett. 2014 Jan 1;342(1):121-9
pubmed: 24001611
Clin Transl Gastroenterol. 2018 Jun 15;9(6):159
pubmed: 29904058
Esophagus. 2019 Jan;16(1):1-24
pubmed: 30171413
Nat Rev Clin Oncol. 2012 Mar 20;9(5):278-87
pubmed: 22430857
Cancers (Basel). 2021 Jan 17;13(2):
pubmed: 33477274
Br J Cancer. 2016 Feb 2;114(3):290-7
pubmed: 26794279
J Gastrointest Cancer. 2019 Jun;50(2):292-297
pubmed: 29435906
Oncol Lett. 2018 Jul;16(1):1196-1204
pubmed: 29963194
Cancer Prev Res (Phila). 2016 Jul;9(7):558-66
pubmed: 27072986
Ann Thorac Surg. 2004 May;77(5):1740-4
pubmed: 15111177
Am J Physiol Gastrointest Liver Physiol. 2020 Mar 1;318(3):G401-G409
pubmed: 31905024
Cancers (Basel). 2021 Jan 29;13(3):
pubmed: 33572780
Cancer Res. 2008 Jan 1;68(1):26-33
pubmed: 18172293
Int J Cancer. 2013 Nov 15;133(10):2454-63
pubmed: 23649428
Dig Dis Sci. 2013 Jul;58(7):1863-70
pubmed: 23504349
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Dig Dis Sci. 2013 Dec;58(12):3483-93
pubmed: 24221338